Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1985; Volume 27,Issue 1
  • You have access
    Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
    R H Lenox, J Ellis, D Van Riper and Y H Ehrlich
    Molecular Pharmacology January 1985, 27 (1) 1-9;
  • You have access
    Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
    J D Marsh and T W Smith
    Molecular Pharmacology January 1985, 27 (1) 10-18;
  • You have access
    A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta 1- and beta 2-adrenergic receptors.
    M D Snavely, M G Ziegler and P A Insel
    Molecular Pharmacology January 1985, 27 (1) 19-26;
  • You have access
    Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate. Different ligand-receptor conformations versus different receptor subclasses.
    G Schreiber and M Sokolovsky
    Molecular Pharmacology January 1985, 27 (1) 27-31;
  • You have access
    Guanine nucleotide-sensitive, high affinity binding of carbachol to muscarinic cholinergic receptors of 1321N1 astrocytoma cells is insensitive to pertussis toxin.
    T Evans, M W Martin, A R Hughes and T K Harden
    Molecular Pharmacology January 1985, 27 (1) 32-37;
  • You have access
    Specific binding of [3H-Tyr8]physalaemin to rat submaxillary gland substance P receptor.
    S W Bahouth, D M Lazaro, D E Brundish and J M Musacchio
    Molecular Pharmacology January 1985, 27 (1) 38-45;
  • You have access
    Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Y Itzhak, J M Hiller and E J Simon
    Molecular Pharmacology January 1985, 27 (1) 46-52;
  • You have access
    Characterization of the relationship between gamma-aminobutyric acid B agonists and transmitter-coupled cyclic nucleotide-generating systems in rat brain.
    E W Karbon and S J Enna
    Molecular Pharmacology January 1985, 27 (1) 53-59;
  • You have access
    Export of cyclic AMP from avian red cells. Independence from major membrane transporters and specific inhibition by prostaglandin A.
    L E Heasley, J Azari and L L Brunton
    Molecular Pharmacology January 1985, 27 (1) 60-65;
  • You have access
    Phosphatidylethanolamine N-methylation and insulin release in isolated pancreatic islets of the rat.
    S G Laychock
    Molecular Pharmacology January 1985, 27 (1) 66-73;
  • You have access
    Characterization of formylmethionyl-leucyl-phenylalanine stimulation of inositol trisphosphate accumulation in rabbit neutrophils.
    P G Bradford and R P Rubin
    Molecular Pharmacology January 1985, 27 (1) 74-78;
  • You have access
    The effect of tryptophan modification on the structure and function of a sea snake neurotoxin.
    M Allen and A T Tu
    Molecular Pharmacology January 1985, 27 (1) 79-85;
  • You have access
    Use of artificial intelligence in structure-activity correlations of anticonvulsant drugs.
    G Klopman and R Contreras
    Molecular Pharmacology January 1985, 27 (1) 86-93;
  • You have access
    Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis.
    J K Batra, L Jurd and E Hamel
    Molecular Pharmacology January 1985, 27 (1) 94-102;
  • You have access
    A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.
    L Cellai, S Cerrini, A Segre, C Battistoni, G Cossu, G Mattogno, M Brufani and E Marchi
    Molecular Pharmacology January 1985, 27 (1) 103-108;
  • You have access
    Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism.
    G A Reed, I O Griffin and T E Eling
    Molecular Pharmacology January 1985, 27 (1) 109-114;
  • You have access
    Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants.
    W H Bulger, V J Feil and D Kupfer
    Molecular Pharmacology January 1985, 27 (1) 115-124;
  • You have access
    Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes.
    A R Steward, G A Dannan, P S Guzelian and F P Guengerich
    Molecular Pharmacology January 1985, 27 (1) 125-132;
  • You have access
    Fetal thymus organ culture as an in vitro model for the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners.
    L Dencker, E Hassoun, R d'Argy and G Alm
    Molecular Pharmacology January 1985, 27 (1) 133-140;
  • You have access
    Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
    A Rosowsky, R A Forsch, J Galivan, S S Susten and J H Freisheim
    Molecular Pharmacology January 1985, 27 (1) 141-147;
  • You have access
    A quantum mechanical approach to the theory of cancer from polynuclear compounds. Metabolic activation and carcinogenicity of extended anilines and aminoazo compounds.
    S N Mohammad
    Molecular Pharmacology January 1985, 27 (1) 148-155;
  • You have access
    Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase.
    R G Moran, P D Colman, A Rosowsky, R A Forsch and K K Chan
    Molecular Pharmacology January 1985, 27 (1) 156-166;
  • You have access
    A method for assessing damage to mitochondrial DNA caused by radiation and epichlorohydrin.
    G Singh, W W Hauswirth, W E Ross and A H Neims
    Molecular Pharmacology January 1985, 27 (1) 167-170;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 27, Issue 1
1 Jan 1985
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics